| scholarly article | Q13442814 |
| P50 | author | Peer Bork | Q7160367 |
| Manuel Banzhaf | Q56153030 | ||
| Frédéric Barras | Q57587018 | ||
| Benjamin Ezraty | Q58125351 | ||
| Jacob Bobonis | Q61312526 | ||
| Anja Telzerow | Q63953162 | ||
| Ana Rita Brochado | Q41048887 | ||
| P2093 | author name string | Béatrice Py | |
| Stephan Göttig | |||
| Joel Selkrig | |||
| Athanasios Typas | |||
| Mikhail M Savitski | |||
| Matylda Zietek | |||
| Natalie Ng | |||
| Stefan Bassler | |||
| André Mateus | |||
| Sunniva Foerster | |||
| Emily Huth | |||
| Jordi Zamarreño Beas | |||
| P2860 | cites work | Construction of Escherichia coli K-12 in-frame, single-gene knockout mutants: the Keio collection | Q22122301 |
| Chemical Probes of Escherichia coli Uncovered through Chemical-Chemical Interaction Profiling with Compounds of Known Biological Activity | Q42924831 | ||
| Quinolone accumulation by Pseudomonas aeruginosa, Staphylococcus aureus and Escherichia coli | Q43736410 | ||
| Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis | Q44116286 | ||
| Fe-S cluster biosynthesis controls uptake of aminoglycosides in a ROS-less death pathway | Q45035874 | ||
| Time-resolved binding of azithromycin to Escherichia coli ribosomes. | Q46205442 | ||
| Ciprofloxacin interactions with bacterial protein OmpF: modelling of FRET from a multi-tryptophan protein trimer. | Q46977976 | ||
| Predictive compound accumulation rules yield a broad-spectrum antibiotic | Q47119940 | ||
| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. | Q47765000 | ||
| Overcoming mcr-1 mediated colistin resistance with colistin in combination with other antibiotics | Q49206197 | ||
| The fascinating but mysterious mechanistic aspects of multidrug transport by MdfA from Escherichia coli | Q49814161 | ||
| Extensive impact of non-antibiotic drugs on human gut bacteria. | Q52647893 | ||
| Functional classification of drugs by properties of their pairwise interactions. | Q54468515 | ||
| Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy | Q57001135 | ||
| Cytoscape: a software environment for integrated models of biomolecular interaction networks | Q24515682 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| The multiple antibiotic resistance regulator MarR is a copper sensor in Escherichia coli | Q27687418 | ||
| One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products | Q27860842 | ||
| Hierarchical modularity and the evolution of genetic interactomes across species. | Q27932016 | ||
| A common mechanism of cellular death induced by bactericidal antibiotics | Q28246128 | ||
| Ion Channel Blockers as Antimicrobial Agents, Efflux Inhibitors, and Enhancers of Macrophage Killing Activity against Drug Resistant Mycobacterium tuberculosis | Q28550401 | ||
| Chemogenomics and orthology-based design of antibiotic combination therapies | Q28817589 | ||
| An integrated approach to characterize genetic interaction networks in yeast metabolism | Q30501688 | ||
| Nonoptimal microbial response to antibiotics underlies suppressive drug interactions | Q33726796 | ||
| The Escherichia coli cmlA gene encodes the multidrug efflux pump Cmr/MdfA and is responsible for isopropyl-beta-D-thiogalactopyranoside exclusion and spectinomycin sensitivity | Q33742450 | ||
| Phenotypic landscape of a bacterial cell | Q33780274 | ||
| Drug interactions and the evolution of antibiotic resistance | Q33792926 | ||
| Large-scale identification and analysis of suppressive drug interactions | Q34799147 | ||
| Transcriptional cross talk within the mar-sox-rob regulon in Escherichia coli is limited to the rob and marRAB operons | Q36197524 | ||
| An Antifungal Combination Matrix Identifies a Rich Pool of Adjuvant Molecules that Enhance Drug Activity against Diverse Fungal Pathogens | Q36304381 | ||
| Bacterial uptake of aminoglycoside antibiotics. | Q37063992 | ||
| Misread protein creates membrane channels: an essential step in the bactericidal action of aminoglycosides | Q37395813 | ||
| Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void? | Q38614305 | ||
| Antibacterial drug discovery in the resistance era. | Q38704810 | ||
| A tool named Iris for versatile high-throughput phenotyping in microorganisms. | Q38955424 | ||
| Detection of NDM-7 in Germany, a new variant of the New Delhi metallo-β-lactamase with increased carbapenemase activity | Q39197730 | ||
| A global genetic interaction network maps a wiring diagram of cellular function | Q39318959 | ||
| High-level fluoroquinolone-resistant clinical isolates of Escherichia coli overproduce multidrug efflux protein AcrA. | Q39475770 | ||
| Prediction of Synergism from Chemical-Genetic Interactions by Machine Learning. | Q39803213 | ||
| Synergistic drug combinations tend to improve therapeutically relevant selectivity | Q39828335 | ||
| Outer membrane permeability barrier to azithromycin, clarithromycin, and roxithromycin in gram-negative enteric bacteria | Q39865041 | ||
| Genetic relationship between soxRS and mar loci in promoting multiple antibiotic resistance in Escherichia coli | Q40286069 | ||
| Pentamidine sensitizes Gram-negative pathogens to antibiotics and overcomes acquired colistin resistance. | Q40306876 | ||
| Systematic discovery of drug interaction mechanisms | Q40366182 | ||
| Prediction of intracellular exposure bridges the gap between target- and cell-based drug discovery | Q41256404 | ||
| In vivo horizontal gene transfer of the carbapenemase OXA-48 during a nosocomial outbreak | Q41438717 | ||
| In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa | Q42108953 | ||
| Azithromycin exhibits bactericidal effects on Pseudomonas aeruginosa through interaction with the outer membrane | Q42112742 | ||
| A complete set of Escherichia coli open reading frames in mobile plasmids facilitating genetic studies | Q42665170 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| Cytoscape | Q3699942 | ||
| P433 | issue | 7713 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 259-263 | |
| P577 | publication date | 2018-07-04 | |
| P1433 | published in | Nature | Q180445 |
| P1476 | title | Species-specific activity of antibacterial drug combinations | |
| P478 | volume | 559 |
| Q91556100 | Anti-HIV agent azidothymidine decreases Tet(X)-mediated bacterial resistance to tigecycline in Escherichia coli |
| Q92450459 | Bringing microbiome-drug interaction research into the clinic |
| Q89510084 | Combinatorial Antimicrobial Susceptibility Testing Enabled by Non-Contact Printing |
| Q93110499 | Comparable Efficacy and Better Safety of Double β-Lactam Combination Therapy versus β‑Lactam plus Aminoglycoside in Gram-Negative Bacteria in Randomized, Controlled Trials |
| Q92797706 | Defining and combating antibiotic resistance from One Health and Global Health perspectives |
| Q62673364 | Drug combinations: a strategy to extend the life of antibiotics in the 21st century |
| Q92462438 | Efficacy of leflunomide combined with ligustrazine in the treatment of rheumatoid arthritis: prediction with network pharmacology and validation in a clinical trial |
| Q100946091 | In vitro activity of biofilm inhibitors in combination with antibacterial drugs against extensively drug-resistant Acinetobacter baumannii |
| Q64938886 | Indole Reverses Intrinsic Antibiotic Resistance by Activating a Novel Dual-Function Importer. |
| Q98204269 | Loop-armed DNA tetrahedron nanoparticles for delivering antisense oligos into bacteria |
| Q98385978 | Mechanisms of drug interactions between translation-inhibiting antibiotics |
| Q64252799 | Membrane charge and lipid packing determine polymyxin-induced membrane damage |
| Q91705959 | Metabolomics-Driven Exploration of the Chemical Drug Space to Predict Combination Antimicrobial Therapies |
| Q64992611 | Minimal exposure of lipid II cycle intermediates triggers cell wall antibiotic resistance. |
| Q92500593 | New Perspectives on Galleria mellonella Larvae as a Host Model Using Riemerella anatipestifer as a Proof of Concept |
| Q99726759 | Novel modifications of nonribosomal peptides from Brevibacillus laterosporus MG64 and investigation of their mode of action |
| Q61795887 | Phenazine production promotes antibiotic tolerance and metabolic heterogeneity in Pseudomonas aeruginosa biofilms |
| Q91145505 | Promoter Activation in Δhfq Mutants as an Efficient Tool for Specialized Metabolite Production Enabling Direct Bioactivity Testing |
| Q96435424 | Pyphe, a python toolbox for assessing microbial growth and cell viability in high-throughput colony screens |
| Q89941037 | Ruthenium based antimicrobial theranostics - using nanoscopy to identify therapeutic targets and resistance mechanisms in Staphylococcus aureus |
| Q58717448 | Silver and Antibiotic, New Facts to an Old Story |
| Q60916390 | Synergistic Impacts of Organic Acids and pH on Growth of Pseudomonas aeruginosa: A Comparison of Parametric and Bayesian Non-parametric Methods to Model Growth |
| Q91559345 | Synthesis and antibiotic activity of novel acylated phloroglucinol compounds against methicillin-resistant Staphylococcus aureus |
| Q91638638 | Testing a Human Antimicrobial RNase Chimera Against Bacterial Resistance |
| Q93099382 | Translating antibiotic prescribing into antibiotic resistance in the environment: A hazard characterisation case study |
| Q58586909 | Using Machine Learning to Predict Synergistic Antimalarial Compound Combinations With Novel Structures |
| Q91943451 | Vanillin mediated green synthesis and application of gold nanoparticles for reversal of antimicrobial resistance in Pseudomonas aeruginosa clinical isolates |
| Q90467696 | Zinc-doped Prussian blue enhances photothermal clearance of Staphylococcus aureus and promotes tissue repair in infected wounds |
Search more.